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Structure-based design and combinatorial chemistry yield low 
nanomolar inhibitors of cathepsin D 
Ellen K Kick*‘, Diana C RoeX2, A Geoffrey Skillman2, Guangcheng Liul, Todd 
JA Ewing2, Yaxiong Sun 2, Irwin D Kuntz2 and Jonathan A Ellmanl 
Background: The identification of potent small molecule ligands to receptors 
and enzymes is one of the major goals of chemical and biological research. Two 
powerful new tools that can be used in these efforts are combinatorial 
chemistry and structure-based design. Here we address how to join these 
methods in a design protocol that produces libraries of compounds that are 
directed against specific macromolecular targets. The aspartyl class of 
proteases, which is involved in numerous biological processes, was chosen to 
demonstrate this effective procedure. 
Results: Using cathepsin D, a prototypical aspartyl protease, a number of low 
nanomolar inhibitors were rapidly identified. Although cathepsin D is implicated 
in a number of therapeutically relevant processes, potent nonpeptide inhibitors 
have not been reported previously. The libraries, synthesized on solid support, 
displayed nonpeptide functionality about the (hydroxyethyl)amine isostere. The 
(hydroxyethyl)amine isostere, which targets the aspartyl protease class, is a 
stable mimetic of the tetrahedral intermediate of amide hydrolysis. Structure- 
based design, using the crystal structure of cathepsin D complexed with the 
peptide-based natural product pepstatin, was used to select the building 
blocks for the library synthesis. The library yielded a ‘hit rate’ of 6-7% at 
1 p,M inhibitor concentrations, with the most potent compound having a Ki 
value of 73 nM. More potent, nonpeptide inhibitors (Ki = 9-l 5 nM) of 
cathepsin D were rapidly identified by synthesizing and screening a small 
second generation library. 
Conclusions: The success of these studies clearly demonstrates the power of 
coupling the complementary methods of combinatorial chemistry and structure- 
based design. We anticipate that the general approaches described here will 
be successful for other members of the aspartyl protease class and for many 
other enzyme classes. 
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Introduction 
A cherished goal of chemists is to design and synthesize 
compounds with a specific set of properties. This goal is 
particularly urgent in biological and medicinal chemistry 
as a part of the drug-discovery process. Two powerful 
new tools that can be used in this effort are structure- 
based design [1,2] and combinatorial chemistry [3,4]. 
Structure-based design uses information gleaned from 
crystallographic and magnetic resonance experiments on 
a target macromolecule, frequently an enzyme, to guide 
the selection or design of inhibitors. Computation is 
important in this process [2,5]. Combinatorial chemistry is 
based on general chemical transformations that allow dif- 
ferent building blocks to be combined in high yield. 
These transformations can be performed in parallel, to 
synthesize libraries of related compounds rapidly and effi- 
ciently [3,4]. Nonetheless, the discovery of a new lead 
compound or the improvement of the properties of an 
existing lead are still demanding tasks. Here, we integrate 
computational and combinatorial methods in a design 
protocol to produce libraries of compounds directed 
against specific macromolecular targets. 
Combinatorial approaches to ligand identification initially 
focused on biopolymer libraries prepared by either chemi- 
cal or biological methods [6]. For these libraries, all possi- 
ble combinations of the building blocks are typically used 
because there are only four natural nucleotide building 
blocks for nucleic acid libraries and 20 proteinogenic 
amino-acid building blocks for peptide libraries. Both the 
structures of the compounds and the theoretical number of 
compounds in the library are determined by the length of 
the biopolymer chain. Recently, considerable efforts have 
been directed towards the preparation of libraries of com- 
pounds that encompass a wider spectrum of chemical trans- 
formations, to produce compounds with a broader range of 
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Figure 1 
Mechanism-based inhibitor design. The 
(hydroxyethyl)amine isostere is a stable 
Intermediate of peptide hydrolysis 
1 2 
(Hydroxyethyl)amine-based inhibitors 
mimetic of the tetrahedral intermediate of 
aspartyl protease catalyzed peptide 
hydrolysis. 
properties than found in peptides or oligonucleotides [3,4]. 
These new approaches introduce significant challenges in 
library design. 
A crucial element of any library design is the procedure 
for selecting which compounds to synthesize. This 
includes the choice of the scaffold, the basic reactions and 
the nature of the building blocks. If the building blocks 
are readily available components such as amines, alde- 
hydes or carboxylic acids, the number of potential com- 
pounds to be considered can be quite large. For example, 
combining three building blocks with thousands of 
components at each position leads to over one billion 
compounds. Although different strategies have distinct 
practical limits, typically one is prepared to synthesize 
only thousands of spatially separate compounds and tens 
of millions of compounds in mixtures. Furthermore, eval- 
uation and deconvolution of a very large library become 
rate-limiting activities [7]. Thus, there would be signifi- 
cant advantages to a method that reduces the synthetic 
effort to a small subset of compounds biased towards the 
desired properties. 
How can the potential choices be efficiently reduced? 
Two standard strategies are diversity selection and 
directed selection. Diversity approaches attempt to maxi- 
mize the sampling of chemical and biological properties in 
a fixed number of compounds [8]. In directed libraries the 
size and often the diversity of the library is reduced by 
selecting those building blocks that are predicted to have 
favorable interactions with the target, or by eliminating 
candidates that are believed to have unfavorable interac- 
tions. A directed library can be designed on the basis of 
substrate preferences, information about known inhibi- 
tors, or, in the work described here, an assessment of the 
potential interaction of specific functional groups with the 
target. Both diversity and directed strategies permit a 
multistage attack with secondary libraries generated from 
active compounds found in the first round. 
The development of general and efficient approaches to 
identify small nonpeptidic inhibitors of proteases contin- 
ues to be of interest because proteases have important 
roles in therapeutically relevant processes [9-121. Proteases 
have also proven to be excellent targets for structure-based 
approaches [13,14]. Our target, cathepsin D, has been 
implicated in tumor metastasis in breast cancer, melanoma 
metastasis [15] and Alzheimer’s disease [16,17]. Potent 
nonpeptide inhibitors of cathepsin D have not been 
reported previously [18]. Here we describe the efficient 
development of a combinatorial library with functionality 
that is selected using structure-based design. These 
studies resulted in the identification of potent inhibitors of 
cathepsin D, that do not contain amino acids and have 
molecular weights under 800 Da. 
Results 
Specific approach 
One powerful strategy to target an enzyme class is to 
incorporate a stable mimetic or isostere of the transition 
state or of an intermediate of the enzyme-catalyzed reac- 
tion [19]. The libraries for potential cathepsin D inhibitors 
are based upon the well-known (hydroxyethyl)amine 
isostere (Fig. 1). For our initial libraries, the P, sidechain 
(R,) is the benzyl substituent, on the basis of the X-ray 
crystallographic structure of cathepsin D complexed with 
the natural peptide inhibitor pepstatin [ZO] and inhibition 
constants of peptide-based inhibitors [21,22]. 
In a pilot study, both S and R epimers at the hydroxyl 
carbon (Fig. 1; structures 1 and 2) were prepared because 
both diastereomers have been found in potent inhibitors 
of other aspartic acid proteases [19]. Because inhibition of 
cathepsin D activity at 1 p,M was only found with com- 
pounds of scaffold 1 in the pilot study, further syntheses 
of libraries used only scaffold 1. Computer modeling (see 
below) predicted that structure 1 (Fig. 1) would provide 
the most potent inhibitors. 
The solid-phase synthesis, which we reported previously 
[23], introduces diversity in three positions: a primary 
amine for the R, substituent and acylating agents for 
the R, and R, substituents (Fig. 2). The library synthesis 
was designed to use commercially available compounds 
for incorporation of the functionality at R,, R,, and R,. 
We began our library design by selecting amines, car- 
boxylic acids, sulfonyl chlorides and isocyanates with 
MW ~275 Da from the Available Chemical Directory 
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Figure 2 
Components employed to prepare the 
libraries targeting cathepsin D. The same 
disconnections provide scaffold 2. 
lsocyanates and sulfonyl chlorides, which can 
be used to incorporate R, and R,, provide 
ureas and sulphonamides, respectively. For 
the synthesis, the scaffold is attached to 
polystyrene resin using a tetrahydropyran 
linker (indicated by the sphere). 
(ACD, version 93.2; from MDL Information Systems, 
San Leandro, CA, USA). We eliminated compounds with 
functionality that was obviously incompatible with our 
synthesis. The resulting list included -700 amines and 
-1900 acylating agents, which would provide access to 
more than one billion compounds. To reduce the 
number of compounds in a sensible way, we turned to a 
computational screening process. 
Directed library design 
We chose a structure-based screening process using a 
new feature for our BIJILDER molecular modeling 
program [24,25], called CombiBuild [26] (see Materials 
and methods section). To begin the design process, the 
Figure 3 
scaffold was modeled in the active site with the assump- 
tion that the binding orientation of the scaffold would be 
similar to pepstatin (Fig. 3a). A conformational search of 
the scaffold identified a number of conformations with 
comparable energies. We clustered these conformations 
into four families on the basis of geometric similarity 
(Fig. 3b). CombiBuild [26] was used to position each of 
the R,, R, and R, components onto the scaffold and to 
perform a full conformational search for the torsion angles 
of the substituent. In order to reduce the combinatoric 
problem, the R,, R, and R, components were examined 
independently, but a probability-based clash grid was con- 
structed to identify R, and R, conformations that might 
overlap. For example, if an R, conformation clashed with 
Designing the combinatorial library with 
CombiBuild. (a) Modeling the scaffold. 
Coordinates and P,-P, conformations of the 
pepstatin inhibitor were used as the starting 
geometry for the (hydroxyethyl)amine scaffold 
(see Materials and methods section). Methyl 
groups were placed at each of the scaffold’s 
R,-R, positions. (b) Scaffold conformation. A 
conformational search about the three torsion 
angles of the scaffold yielded four 
conformational families. A benzyl sidechain 
(Bn) was added to each of these families at 
the R, position. (c) Evaluating library 
components. The program CombiBuild 
performed a conformational search on all 
possible components at each variable position 
(R,-R3) on each family and scored the 
components by their potential interaction with 
cathepsin D. The top scoring candidates for 
each family were merged. 
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Directed library components. Each 
component is labeled with a letter code. EHA 
is defined as R, =E, R,=H and R,=A. 
more than 50% of the R, components, that conformation 
was discarded. Components from all of the conformational 
families were merged. Then, based on AMBER score, the 
fifty best components at each position were selected (see 
Materials and methods section). The 50 best-scoring com- 
ponents for all conformational families were merged for 
each of the three variable positions. Components with 
cost above $35 per gram were removed. The remaining 
compounds were hierarchically clustered to maximize the 
diversity of the top-ranking compounds that were 
selected for library synthesis. For R,, R, and R,, the ten 
best-scoring compounds from unique clusters were 
selected for each position. 
Diverse library design 
A diverse library, the same size as the directed library, was 
prepared as a control to provide a ‘hit’ rate when structure- 
based methods are not employed. The diverse library was 
designed to maximize the variety of functional groups and 
structural motifs of the library components. The 
sidechains for this library were selected by clustering the 
original list of components on the basis of their similarity 
to each other. Components were clustered with the 
Jarvis-Patrick algorithm [27] using the Daylight connec- 
tivity measure of similarity (Daylight Clustering Toolkit, 
. 
v. 4.42; Daylight Chemical Information Systems, Inc., Santa 
Fe, NM, USA) and a binary Tanimoto metric [28,29] (see 
the Materials and methods section). 
Library synthesis and screening 
The directed and diverse libraries (1000 compounds each) 
were prepared using diastereomer 1 of the (hydroxy- 
ethyl)amine scaffold with the components used in library 
syntheses shown in Figures 4 and 5, respectively. Because 
the pilot study with R and S epimers only showed activity 
at 1 p,M inhibitor concentration for the S epimers, only the 
S epimers of the directed and diverse library were synthe- 
sized. The libraries of spatially separate compounds were 
prepared by multiple parallel synthesis, and were 
screened in a high through-put fluorometric assay for 
inhibitory activity against cathepsin D [30]. 
Assay results 
Using -1 p,M of crude compound, the directed library 
yielded 67 compounds that inhibited cathepsin D activity 
250%. Further dilution to 333nM and 1OOnM inhibitor 
concentrations afforded 23 and 7 compounds, respectively, 
that inhibited cathepsin D activity 250% (Table 1). The 
data for the diverse library are also in Table 1. There are 
many uncertainties that can influence the results of a high 
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Figure 5 
Diverse library components. Each component 
is labeled by a lower case letter code in a 
similar manner to Figure 4. *The f-butyl ester 
of R, =i was used in the coupling reaction. 
+The Boc protected amine of R,=d was used 
in the coupling reaction. These protecting 
groups are removed during the cleavage step. 
g h if i 
R2 substftuent 
through-put fluorescence assay, including the purity of 
each compound, the concentration of the compounds, and 
the experimental errors associated with the microtiter fluo- 
rescence assay. From repetitive experiments we estimate 
these errors to be -3O%, expressed as enzyme activity. 
In order to obtain accurate inhibition constants (K;), 
several compounds judged to be potent inhibitors on the 
basis of the library screening were synthesized on a larger 
scale, purified by chromatography, and characterized by 
nuclear magnetic resonance (NMR) and mass spectrome- 
try. The Ki values were calculated from IC,, determina- 
tions (Table 2). From the compounds that were fully 
characterized, we obtained one compound from the 
directed library with a Ki below lOOnM, whereas the 
diverse library contained inhibitors that were three to four 
times less potent. 
Second generation library 
As a separate experiment, we explored a simple optimiza- 
tion strategy to identify compounds with improved 
binding affinity. We chose the directed library for this test. 
In the design of the directed library, we had selected 
derivatives by applying a clustering algorithm (see Directed 
library design section). We re-examined these clusters to 
expand upon the important structural elements of the 
most active compounds. In particular, we synthesized and 
screened a second generation library of 39 compounds 
from the clusters for the R,, R, and R, positions that pro- 
vided the most active compounds (Fig. 6). At 1 l&I, 92% 
of the compounds that were screened inhibited cathepsin D 
Table 1 
Number of compounds inhibiting cathepsin D. 
Library 
[Inhibitor1 Directed Diverse* 
100nM 7+ 15 
330 nM 23* 31 
1 PM 67 26 
1OpM 11195# 
Compounds that inhibit t50% of cathepsin D activity at respective 
concentrations: EAA, EFA, EHA, EHD, EHI, EHJ, and FHA. An 
additional six compounds provided 40-50% inhibition of cathepsin D. 
‘EAA, EFA, EHA, FAA, FFA, FHA, EHB, EFD, EHD, EEF, EHF, FHF, 
EFH, EHH, FAH, FFH, EFI, EHI, EAJ, EFJ, EGJ, EHJ, and FHJ. An 
additional 30 compounds provided 40-50% inhibition of cathepsin D. 
#lOO compounds were selected by random number generation for 
testing at 10 PM. Five compounds were highly fluorescent at these 
concentrations, so that accurate assay data could not be obtained in 
these cases. sfbb. nfba, fbb, and fcb. Four compounds (fca, fdb, fib, 
and hhb) provided 40-50% inhibition of cathepsin D; with the 
experimental error in the assay, this activity is similar to the activity for 
the three that are listed. *The diverse library was not tested at 10 FM. 
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Table 2 
Inhibition constants for selected compounds. 
Inhibitor Cmp code K, (nM) 
Cl 
EHD 73 f 9 
(R)- EHD >5000 
EHJ 111 f 6 
EHA 131 f 12 
EFA 171 f 25 
FHA 231 k 31 
fbb 356 f 31 
fdb 595 k 66 
Inhibition constants (K,) were determined for several of the ‘hits’ from 
the designed and diverse libraries. The Ki values were determined from 
the IC,, values (see Materials and methods section). 
250%, and 18% of the compounds at 100nM inhibited 
cathepsin D 250%. Inhibition constants were determined 
for selected compounds (Table 3), providing several 
potent inhibitors (Ki I15 nM) of cathepsin D. 
Discussion 
Novel low nanomolar inhibitors of cathepsin D were iden- 
tified rapidly using combinatorial chemistry coupled with 
two different computational strategies. The diverse and 
directed libraries together, not including the optimization 
experiment, yielded over 90 compounds that were active 
at 1 p,M and 26 compounds that were active in the sub- 
micromolar range. The ‘hit rate’ for activity at 1 pM is 
6-7% for the directed library and Z-3% for the diverse 
library. When screening was performed at concentrations 
below 1 FM, there were seven times more ‘hits’ in the 
directed library than the diverse library. The most potent 
inhibitors from the directed library are threefold to four- 
fold better inhibitors than those in the diverse library. For 
the first round of synthesis and screening the number and 
potency of the active compounds were higher when the 
structural information of cathepsin D was used. 
The experimental data collected in this project give a first 
picture of the distribution of activity within a library 
(Fig. 7). Although we have extended results only for the 
directed library, the pattern, as one might expect, shows a 
relatively steep reduction in the number of compounds 
that are active at low concentrations, roughly a factor of 
ten for each decade reduction in IC,,. Because the limit- 
ing slope for the diverse library is similar to that for the 
directed library, these results suggest that roughly ten 
times the number of compounds would have to be synthe- 
sized for the diverse library to yield the same results as the 
directed library. These data also provide a basis for testing 
different theoretical models of ligand binding. 
A strength of the structure-based procedure is that it leads 
directly to testable geometrical hypotheses. In this study, 
there are three hypotheses. First, S epimers are predicted 
to bind better than the R epimers; second, there are two 
energetically reasonable scaffold conformations (Fig. 3; 
family 1 + 2, family 3 +4), which place R groups into dif- 
ferent pockets; third, all the inhibitors are assumed to 
bind in approximately the same orientation as pepstatin. 
The first hypothesis was directly tested in pilot experi- 
ments in which no inhibitors that were based upon the R 
epimer had activity at 1 p,M. In addition, the R epimer of 
one of the most potent compounds had a Ki that was no 
better than 5 ~.LM whereas the Ki of the S epimer was 
15 nM (Table 3). This conclusion and the inhibitor orien- 
tations in the cathepsin D complex will be examined by 
X-ray crystallography. 
The computational approach outlined in this paper is most 
applicable when the scaffold orientation can be restricted 
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Figure 6 
Components in each of the clusters (see 
Directed library design section) that contained 
the most active sidechains, R, = E, F; R,= F, 
H; R,=A, D, J. 39 compounds incorporating 
these sidechains were synthesized on resin as 
described previously: EFD, EHD, FFD, FHD, 
KFD, KHD, LFD, LHD, MFD, MHD, NFD, 
NHD, OFD, OHD, PFD, PHD, QFD, QHD, 
RFD, RHD, SFD, SHD, TFD, THD, UFD, UHD, 
VFD, VHD, EHA, EHJ, EHK, EHL, EHM, EHN, 
EHO, EHP, EHQ, EHR, and EHS. The 
compounds were assayed at 1 ~.LM, 333 nM, 
100 nM and 33 nM in high through-put 
screening. The most active compounds were 
synthesized on a large scale and the Ki values 
were determined (see Table 3). 
R, substituent 
{rNH2 &~)J’J-~~~ 3’3-NH2 
F~N’2&~H2 IrNH’ ~NH~ IrNH2 
M N 0 P 0 
&yH2 $JH2 FFNH2 MrNH2 0”““’ 
U V 
R3 substituent 
Br 0 
giloH OH 
Me 
R OMe s 
using information from the structures of complexes. We 
are developing methods that will work even if the scaffold 
orientation is unknown or uncertain (Y.S., T.J.A.E., and 
I.D.K., unpublished observations). One of these methods 
docks scaffolds and sidechains simultaneously. Another 
method docks sidechains separately and then links them. 
With these methods we overcome the combinatorial 
explosion normally associated with generating all possible 
combinations in advance. Ultimately, the complexities of 
combinatorial chemistry may require different computa- 
tional strategies for the design of the full range of 
oligomeric and small molecule libraries. 
The work presented here is seen as the first stage of a 
process in which active compounds are identified and 
then, in later stages, the activity is optimized. The opti- 
mization criteria can include improved potency, selectiv- 
ity, pharmacokinetic properties, or reduced toxicity. Each 
of these issues appears amenable to library design. For 
example, compounds with fivefold to sixfold improved 
potencies were rapidly identified by synthesizing and 
screening a small second generation library that explored 
variants of the most active compounds. This strategy is 
straightforward and can be readily applied to both directed 
and diverse libraries. 
The success of the directed library towards finding potent 
inhibitors demonstrates the power of coupling combina- 
torial libraries with structure-based design. Combinatorial 
libraries allow a larger area of molecular space to be 
explored with the functionality selected by the structure- 
based design, removing the need to identify in advance a 
single ‘best’ target. Similarly, computational methods 
allow the rapid examination of extremely large virtual 
regimes (> lOlo compounds) and focus the chemical efforts 
into productive regimes. Diverse libraries remain an 
important strategy in the absence of target information 
and always offer the potential advantage of a wider range 
of lead candidates. 
Significance 
The. identification of potent small molecule ligands for 
receptors and enzymes is one of the major goals of chem- 
ical and biological research. Two powerful new tools in 
these efforts are structure-based design and combinator- 
ial chemistry. In the present work, we have integrated 
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Table 3 Figure 7 
Second generation library inhibition constants (KJ. 
Inhibitor 
Cmp IC,, Ki 
code (nM) (nM) 
EHO 19 + 2 
WEHO >5000 
FHO 
EHM 
EHR 
EHS 
UHD 
18+2 
14*2 
20 * 2 
64 k 6 
229 k 44 
15 
14 
9 
15 
59 
224 
inhibition constants (K,) were determined for selected compounds from 
the second generation library. The K, values were determined from the 
IC,, values shown (see Materials and methods section). 
these approaches to develop a general method for the 
rapid identification of potent enzyme inhibitors. We have 
demonstrated this method by identifying potent, nonpep- 
tide inhibitors (& = 9-15 nM) of cathepsin D, a prototypi- 
cal aspartyl protease that has been implicated in a 
number of therapeutically relevant processes, but for 
which potent nonpeptide inhibitors have not previously 
been reported [18]. 
The significance of this study is threefold. First, this 
general method should be directly applicable to the rapid 
identification of potent inhibitors of the other members 
Distribution of activity o Model 
1 Directed 
10-4 I ~ 
-10 -8 -6 -4 -2 0 2 
log W,,) 
Normalized number of active compounds at each activity in directed 
and pilot libraries (squares) as a function of log (activity). The point at 
1 Oe3 is an upper limit. A very simple model is consistent with these 
data and illuminates some characteristics of the distribution of activity 
(circles). In the model, each molecule is assumed to be made of M, 
small units. If each unit has a probability, p, of yielding a favorable 
binding interaction of strength E, and a 1 - p chance of an interaction 
strength 0, then the number of molecules, N(E), having an interaction 
energy of E= M x E, where M  lies between 0 and M,, is given by a 
binomial distribution. If p=O.5, N(E)=M,!/(M!x(M,-M)!). This 
distribution has a maximum affinity (E=M,xe), followed by a rapid 
increase in the number of molecules with diminishing activity. 
Interestingly, the distribution has a maximum probability and decreases 
as the binding affinity approaches 0. If M, is chosen as 10, 
E= 1.4 kcal mol-‘, N(E) is converted to a probability by normalization, 
and the model matched to the directed library data by an offset 
constant of 2.8 kcal mol-I, the model tracks the experimental results 
fairly closely. The model as described has only three parameters that 
determine the shape of the curve. It is far too simple to be used in a 
quantitative manner. It may serve to stimulate further measurements 
and analysis, however. 
of the aspartyl protease class. Second, with careful 
selection of the appropriate scaffold, we anticipate that 
the general approaches described here will also be suc- 
cessful for many other enzyme classes. Third, the 
success of this work clearly demonstrates the power of 
coupling the complementary approaches of combinator- 
ial chemistry and structure-based design. 
Material and methods 
Directed library design 
The structure-based design process began with coordinates for pep- 
statin in a complex with cathepsin D [201. Using the standard nomen- 
clature [311, the scaffold is identical to pepstatin on the P,-P, side, but 
differs on the P,,-PZ side and cannot form the same hydrogen bonds 
with the enzyme (Fig. 3a). Thus, we used the pepstatin positions for the 
P,-P, side and systematically rotated the three scaffold torsion angles 
on the P,.-P, side. Each rotation was followed by energy minimization 
within the cathepsin D active site, using the AMBER 1321 force field in 
the program Sybyl, a molecular modeling software package (Tripes 
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Associates, St Louis, MO, USA). During minimization, the enzyme was 
kept rigid but full flexibility of the scaffold was allowed. Both S and R 
epimers, structures 1 and 2, were modeled using methyl groups for 
each of the R,-R, groups. The conformational energies of the R 
epimers were generally -2 kcal higher than for S epimers, leading us to 
predict that the S epimers would bind more tightly than the R epimers. 
All minimized conformations of S epimers within a 2 kcal mole1 range 
were collected and clustered into four families based on geometric 
similarity (Fig. 3b). A benzyl group was added to each family at the R, 
position. The processed list of compounds from the ACD was passed 
through Sybyl to obtain Gasteiger and Marsili partial atomic charges for 
each component [33,34]. To reduce the computational time for search- 
ing the components, compounds with more than 4 torsional bonds 
were identified and removed. A new feature for our BUILDER molecular 
modeling program [24,25], called CombiBuild [26], was used to posi- 
tion each of the R,, R, and R, components onto the scaffold and to 
perform a full conformational search for the torsion angles of the sub- 
stituent at 15 degree increments. In order to reduce the combinatoric 
problem, the R,, R, and R, components were examined independently, 
but a probability-based clash grid was constructed to identify R, and 
R, conformations that might overlap. For example, if an R, conforma- 
tion clashed with more than 50% of the R, components, that conforma- 
tion was discarded. Each rotation was then examined for intramolecular 
clashes with the scaffold and overlap with cathepsin D. Each accepted 
conformation was rigid-body minimized [351 and scored with a force- 
field grid [36]. The total computer time required to evaluate all torsion 
angles for all sidechains attached to four different scaffold conforma- 
tions was 16 h on a Silicon Graphics Iris R4400. The 50 best scoring 
components for all families were merged for each of the three variable 
positions, and sorted by overall lowest score. Components with cost 
above $35 per gram were removed, leaving 34, 35 and 41 compo- 
nents at R,, R, and R,, respectively. Each remaining component was 
structurally fingerprinted using the Daylight software (Daylight Cluster- 
ing Toolkit, v. 4.42, Daylight Chemical Information Systems, Inc., Santa 
Fe, NM, USA) and hierarchically clustered (similarity cutoff =0.63) [37] 
using the Tanimoto similarity metric [28,29]. For R,, R, and R,, the ten 
best-scoring components from unique clusters were selected for the 
directed library. 
Diverse library design 
Components from the original ACD list were clustered with the 
Jarvis-Patrick algorithm [27] using the Daylight connectivity measure of 
similarity and a binary Tanimoto metric [28,291. In the Jarvis-Patrick 
method, two compounds are placed in the same cluster if they are neigh- 
bors of one another and share at least p neighbors from a list of q nearest 
neighbors, where p and q are adjustable parameters. The compound 
nearest the cluster centroid was chosen as the cluster representative. 
The R, (amine) components were clustered directly as the primary 
amines. The R, and R, acylating agents were each attached to a 
portion of the scaffold before clustering to yield the proper chemical 
context at the linkage site. The first round of clustering yielded 47, 154 
and 162 clusters using p/q = 4111, p/q = 4/l 2, and p/q = 4/l 2 for R,, 
R, and R,, respectively. The representative R, and R, components 
were clustered a second time (p/q = 4/7 for R, and p/q = 4/7 for Rs), 
resulting in 23 R, and 35 R, components. We note that it is not practi- 
cal to condense a large number of compounds into an arbitrarily small 
number of clusters because the cluster membership can become very 
diverse. Final selection of ten compounds from each list was based 
upon size, cost, availability and synthetic feasibility. Additionally, we 
sought a balance of functional groups for each set of sidechains. A 
comparison of the directed and diverse libraries (Figs 4,5) shows the 
much greater range of functionality spanned in the diverse library. 
Library synthesis 
We have previously reported the optimization of the solid-phase syn- 
thesis sequence to prepare the (hydroxyethyl)amine inhibitors and the 
demonstration of reaction generality 1231. Further testing was per- 
formed to establish that the different functionality to be displayed at R,, 
R, and R, would be successfully incorporated into the potential 
inhibitors. First, all the amines and acylating agents to be incorporated 
in both the diverse and directed libraries were treated with trifluo- 
roacetic acid for 2 h at room temperature to ensure stability to the 
support-cleavage conditions, which are by far the harshest reaction 
conditions in the synthesis sequence. Second, components that might 
pose difficulties on chemical or steric grounds were evaluated by incor- 
porating them into syntheses of potential (hydroxyethyl)amine inhibitors 
on the basis of the synthetic protocol previously described [23]. These 
compounds were then purified by chromatography and analyzed by 
NMR and mass spectrometry. Five amines and four carboxylic acids 
that did not provide the expected final compound in high yields or 
purity were discarded. The following amines and acylating agents were 
successfully tested in the synthesis sequence: R, = B, C, E, F, a, e, h, i, j; 
R,= B, C, D, E, H, a, e, f; R, = A, D, E, H, a, b, e, g, i. The remaining 
components were assumed to be compatible with the synthesis 
sequence due to their similarity to sidechains that previously had been 
successfully incorporated. 
The library synthesis was performed on polystyrene beads (20-40 
mesh) prepared in our laboratory. The library was synthesized in a spa- 
tially separate array using a 96-well filter apparatus. Transfer of the 
resin to the individual wells was performed using an isopycnic mixture 
of /V,N-dimethylformamide (DMF) and 1,2-dichloroethane. Incorpora- 
tion of R, was carried out using 1 .O M amine in /V-methylpyrrolidinone 
(NMP) at 80°C for 36 h. Incorporation of R, was carried out using 
stock solutions of 0.3 M  carboxylic acid, 0.3 M  benzotriazole-1 -yl-oxy- 
tris-pyrrolidino-phosphonium hexafluorophosphate (PyBOP), 0.3M 7-aza- 
I-hydroxybenzotriazole (HOAt), and 0.9 M  iPr,EtN in NMP overnight. 
The coupling reactions were performed twice to ensure that complete 
coupling had occurred. After azide reduction with SnCI,, PhSH and 
Et,N, incorporation of R, was carried out as reported above for R,. 
Carboxylic acid R, = E was coupled using 0-(7.azabenzotriazol-1 -yl)- 
1 ,1,3,3-tetramethyl-uronium hexa-fluorophosphate (HATU) instead of 
PyBOP due to formation of a precipitate under the standard coupling 
procedure. The isocyanate R, = b was coupled at 0.3 M  in NMP 
overnight, and the sulfonyl chlorides R, = e and R, = c were coupled 
at 0.3 M  in NMP that was 0.9M in /Pr,EtN. Cleavage of the material 
from support was achieved by subjecting the resin to trifluoroacetic 
acid : Hz0 (95:5) for 30 min, followed by rinsing the resin and concen- 
tration of the filtrates using a Jouan 10.10 centrifugation concentrator. 
Toluene was added to form an azeotrope with trifluoroacetic acid 
during the concentration step. After concentration, the libraries were 
stored at -20°C. 
Compounds from each library, picked by random number generation, 
were analyzed by mass spectrometry in a matrix of oc-cyano-4-hydroxy- 
cinnamic acid on a Perseptive Biosystems MALDI instrument. For the 
diverse library the expected molecular ion peaks were observed for 46 
of 49 compounds (poor ionization was obtained for the other three). 
Molecular ion peaks were obtained for 44 of 49 compounds from the 
directed library. In addition, the synthesis has been validated by the rea- 
sonable correlation of the approximate IC,, values of the crude material 
from the libraries with purified material that was synthesized on large 
scale for a number of compounds (see Table 2). 
High through-put cathepsin D assay 
A fluorometric high through-put assay for inhibitor activity towards 
human liver cathepsin D (Calbiochem) was performed in 96-well 
microtiter plates [30]. The peptide substrate (Ac-Glu-Glu(Edans)- 
Lys-Pro-lle-Cys-Phe-Phe-Arg-Leu-Gly-Lys(Methyl Red)-Glu-NH,) 
used in the assay has been previously reported (K,= 6pM) [20]. The 
assay was performed in DYNATECH Microfluor fluorescence microtiter 
plates, and readings were taken on a Perkin-Elmer LS-SOB with an 
attached 96-well plate reader. The excitation wavelength was 340 nm. A 
340 nm interference filter (Hoya, U-340) for excitation and a 430 nm cut- 
off filter for emission were used. For the microtiter-based assays the sub- 
strate concentration was 5 FM and the cathepsin D concentration was 
3-4nM in a 0.1 M  formic acid buffer (pH=3.7). Dimethylsulphoxide 
(DMSO; 10%) was used to ensure complete dissolution of the 
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inhibitors, The fluorescent unit readings were taken at three time points 
within the linear region of the substrate cleavage, and percentage activ- 
ity of the enzyme was determined by comparing the change of fluores- 
cent units (FU) for each well to the average change in FU for six control 
wells without inhibitor. Each library was screened at approximately 
1 PM inhibitor with the concentration based on the assumption that 
50% of the theoretical yield was obtained for each inhibitor. All com- 
pounds that inhibited t50% cathepsin D activity were screened at sub- 
sequent threefold dilutions. All active compounds that inhibited >40% 
cathepsin D activity at 1 PM or lower inhibitor concentrations were 
assayed in duplicate. 
Synthesis of inhibitors 
Several of the most potent compounds from the designed and diverse 
libraries were synthesized on a 30 milligram scale on the solid-support 
following the previously reported method 1231. These compounds 
were purified by column chromatography, and characterized by ‘H 
NMR and either mass spectrometry or elemental analysis. The char- 
acterization data are listed below after the appropriate compound 
code. The IH NMR is only reported for the major amide rotomer for 
each compound. 
EHA. 1H NMR (300 MHz, CDCI,) 6 2.43 (m, 2H), 2.55 (t, J= 7.2 Hz, 
2H), 2.62-2.83 (m, 4H), 2.88 (dd, J = 2.3, 14.3 Hz, lH), 3.27-3.36 
(m,2H),3.48(dd,J=8.7,14.3Hz,1H),3.70(d,J=8.0Hz,1H),3.85 
(t, J= 7.2 Hz, 2H), 4.03-4.14 (m, 3H), 5.91 (s, lH), 5.92 (s, lH), 6.44 
(dd, J= 1.6, 7.9 Hz, lH), 6.52 (d, J= 1.6 Hz, lH), 6.66 (d, J= 7.9 Hz, 
1 H), 7.03-7.26 (m, 9H), 7.70 (dd, J= 3.0, 5.4 Hz, 2H), 7.81 (dd, J= 
3.0, 5.4 Hz, 2H). LRMS (MALDI-TOF) a-cyano-4-hydroxycinnamic acid 
matrix: mass calc’d for C,,H,,N,O, (MH+) 719.3, found 718.7. Anal. 
calc’d for C,,H,,N,O,: C, 66.84; H, 5.33; N, 7.79. Found: C, 66.67; 
H, 5.20; N, 7.97. 
EHD. IH NMR (300 MHz, CDCI,) 6 2.43-2.54 (m, 2H), 2.76 (t, J = 
7.6Hz, 2H), 2.92-2.98 (m, 2H), 3.02 (dd, J= 1.9, 14.2 Hz, 1 H), 3.34 
(m, 2 H), 3.68 (dd, J = 8.9, 14.2 Hz, lH), 3.82-4.01 (m, 3H), 4.19 
(apparent q, J = 8.0 Hz, 1 H), 4.40 (d, J = 14.3 HZ, 1 H), 4.51 (d, J = 
14.3 Hz, 1 H), 5.91 (d, J= 1.5 Hz, lH), 5.92 (d, J= 1.5 Hz, lH), 6.45 
(dd, J= 1.6, 7.9 Hz, lH), 6.53 (d, J= 1.6 Hz, lH), 6.66 (d, J= 7.9 Hz, 
lH), 6.95 (s, lH), 7.17-7.28 (m, 5H), 7.49 (s, lH), 7.71 (dd, J=3.1, 
5.5 Hz, 2H), 7.82 (dd, J = 3.1, 5.5 Hz, 2H). LRMS (MALDI-TOF) OL- 
cyano-4-hydroxycinnamic acid matrix: mass calc’d for C,,H,,N,O,CI, 
(MH+) 766.1, found 767.1. 
EHJ. ‘H NMR (300 MHz, CDCI,) 6 2.37-2.56 (m, 2H), 2.63 (t, J= 6.8, 
2H), 2.98-3.01 (m, 2H), 3.14 (d, J= 11.2, lH), 3.41 (m, 2H), 3.82 (s, 
3H), 3.86 (s, 3H), 3.76-3.90 (m, 4H), 4.33 (apparent q, J = 8.0 Hz, 
1 H), 5.87 (d, J = 1.3 Hz, 1 H), 5.89 (d, J = 1.3 Hz, 1 H), 6.45 (dd, J = 
1.6, 7.9 Hz, 1 H), 6.49 (d, J = 1.6 Hz, 1 H), 6.63 (d, J = 7.9 Hz, 1 H), 
6.77(d,J=9.2Hz, lH),6.78(d,J=8.7Hz,lH),7.18(d, J=8.7Hz, 
lH), 7.24-7.28 (m, 5H), 7.69 (dd, J= 3.0, 5.4 Hz, 2H), 7.79 (dd, J = 
3.0, 5.4). LRMS (MALDI-TOF) o-cyano-4-hydroxycinnamic acid matrix: 
mass calc’d for C,,H,,N,O,CI (MH+) 728.2, found 727.9. 
EFA. 1H NMR (300 MHz, CDCI,) 6 2.10-2.33 (m, 2H), 2.49 (t, J = 
6.7 Hz, 2H), 2.47-2.86 (m, 7H), 3.17-3.33 (m, 2H), 3.58-3.69 (m, 2H), 
4.02-4.14 (m, 3H), 5.90 (s, 2H), 6.38 (dd,J= 1.6, 7.9 Hz, lH), 6.47 (d, 
J=1.6Hz, lH),6.67 (d,J=7.9Hz, lH),6.88 (dd,J=2.0,8.2 Hz, lH), 
7.02-7.26 (m, lOH), 7.29 (d, J= 8.2 Hz, 1H). LRMS (MALDI-TOF) o- 
cyano-4-hydroxycinnamic acid matrix: mass calc’d for Cs,H,,N,O,CI, 
(MH+) 718.2, found 719.0. 
FHA. 1H NMR (300 MHz, CDCI,) 6 2.46 (m, 9H), 2.94 (dd, J = 2.3, 
14.3 Hz, 1 H), 3.33 (apparent q, J = 7.0 Hz, 1 H), 3.46 (dd, J = 8.8, 
14.3 Hz, lH), 3.73 (d, J = 8.2 Hz, lH), 3.89 (t, J = 7.3 Hz, 2H), 
4.02-4.16 (m, 3H), 6.43 (d, J = 9.2 Hz, lH), 6.98-7.26 (m, 1 lH), 
7.32 (d, J= 2.1 Hz, lH), 7.70 (dd, J=3.2, 5.4 Hz, 2H), 7.82 (dd, J= 
3.2, 5.4 Hz, 2H). LRMS (MALDI-TOF) cy-cyano-4-hydroxycinnamic acid 
matrix: mass calc’d for C3sH37N407C12 (MH+) 743.2, found 743.0. 
fbb. ‘H NMR (300 MHz, CDCI,) 6 0.64-l .89 (m, 1 OH), 2.67 (t, J = 
6.4Hz, 2H), 2.79 (t, J= 6.7 Hz, lH), 2.86-2.96 (m, 3H), 3.26 (t, J= 
6.4 Hz, 2H), 3.43 (t, J= 6.8 Hz, lH), 3.77-3.87 (m, 5H), 4.06 (d, J= 
7.2 Hz, lH),4.09 (d, J=7.2 Hz, lH), 4.63 (s, 2H), 6.45 (d, J=9.2 Hz, 
lH), 6.64-6.82 (m, 3H), 7.18-7.31 (m, 6H). FABHRMS: 613.2519 
(M++H, C,,H,,N,O,S, requires 613.2518). 
fdb. ‘H NMR (300 MHz, CDCI,) 6 0.87 (t, J= 6.8 Hz, 4H), 1.20-l .26 
(m, 8H), 1.47-1.58 (m, 2H), 1.95-2.14 (m, 2H), 2.67 (t, J= 7.2 Hz, 
2H), 2.90-3.01 (m, 2H), 3.34-3.55 (m, 2H), 3.64-3.90 (m, 2H), 3.79 
(s, 3H), 4.08 (m, 2H), 4.63 (s, 1 H), 6.40 (d, J= 9.0 Hz, 1 H), 6.62-6.78 
(m, 3H), 7.18-7.31 (m, 6H). FABHRMS: 600.2555 (M++H, 
C,,H,,N,O,S, requires 600.2566). 
EHM. lH NMR (300 MHz, CDCI,) S 2.48 (m, 2H), 2.60 (m, 2H), 2.94 
(m, 2H), 3.03 (dd, J = 1.7, 14.8 Hz, 1 H), 3.37 (m, 2H), 3.68 (dd, J = 
8.9, 14.2 Hz, 1 H), 3.83-4.00 (m, 3H), 4.20 (apparent q, J = 8.2 Hz, 
lH), 4.42 (d, J= 14.5 Hz, lH), 4.51 (d, J= 14.5 Hz, lH), 5.91 (s, 2H), 
6.46 (dd, J = 1.6, 7.9 Hz, 1 H), 6.53 (d, J = 1.6 Hz, 1 H), 6.65 (d, J = 
7.9 Hz, lH), 6.76 (d, J= 8.8 Hz, lH), 7.17 (dd, J= 2.6, 8.8 Hz, lH), 
7.20-7.26(m,5H),7.40(d, J=2.6Hz, lH),7.71 (dd, J=3.1,5.4Hz, 
2H), 7.83 (dd, J = 3.1, 5.4 Hz, 2H). LRMS (MALDI-TOF) o-cyano-4- 
hydroxycinnamic acid matrix: mass calc’d for Cs,H,,NsOsCI, (MH+) 
732.2, found 732.5. 
EHO. IH NMR (400 MHz, CDCI,) 6 2.47 (m, 2H), 2.62 (t, J- 7.1 Hz, 
2H), 2.86-2.99 (m, 3H), 3.32-3.41 (m, 2H), 3.68 (dd, J= 8.8, 14.4Hz, 
1 H), 3.79 (d, I = 8.6 Hz, 1 H), 3.88-3.95 (m, 2H), 4.19 (apparent q, J= 
8.1 Hz, lH),4.38(d,J=14.7Hz, lH),4.47(d,J=14.7Hz,lH),4.83 
(s, lH), 5.92 (d, J= 1.4 Hz, lH), 5.93 (d, J= 1.4 Hz, lH), 6.45 (dd, J= 
1.5, 7.9 Hz, 1 H), 6.53 (d, J = 1.5 Hz, 1 H), 6167 (d, J = 7.9 Hz, 1 H), 
6.77 (dd, JE = 2.9, 8.8 Hz, lH), 6.91 (d, J= 9.5 Hz, 1 H), 7.03 (d, J= 
2.9 Hz, lH), 7.20-7.28 (m, 5H), 7.35 (d, J=8.8 Hz, lH), 7.72 (dd, J= 
3.0, 5.4 Hz, 2H), 7.83 (dd, J = 3.0, 5.4 Hz, 2H). FABHRMS: m/e 
732.1879 (M+ + H, C,,H,,N,O,Clz requires 732.1879). 
EHR. ‘H NMR (300 MHz, CDCI,, CDsOD) 6 2.40 (m, 2H), 2.58 (t, J= 
7.0 Hz, 2H), 2.82 (m, 2H), 2.98 (dd, J=3.4, 14.1 Hz, lH), 3.31-3.46 
(m, 3H), 3.74-3.88 (m, 3H), 4.13 (m, 1 H), 4.32 (d, J = 14.8 Hz, 1 H), 
4.41 (d, J= 14.8 Hz, lH), 5.84 (s, 2H), 6.41 (dd, J= 1.6, 7.9 Hz, lH), 
6.49 (d, J= 1.6 Hz, 1 H), 6.60 (d, J= 7.9 Hz, 1 H), 6.74 (dd, b 1.9, 8.3 
Hz, lH), 6.89 (m, lH), 6.94 (d, J = 8.0 Hz, lH), 7.07-7.22 (m, 6H), 
6.67 (dd, J = 3.1, 5.4 Hz, 2H), 7.78 (dd, J = 3.1, 5.4 Hz, 2H). LRMS 
(MALDI-TOF) o-cyano-4-hydroxycinnamic acid matrix: mass calc’d for 
C,,H,,N,O,CI (MH+) 698.2, found 698.0. 
EHS. ‘H NMR (300 MHz, CDCI,) 6 2.49 (m, 2H), 2.65 (t, J= 7.1 Hz, 
2H), 3.02 (m, 2H), 3.15 (d, J = 12.7 Hz, 1 H), 3.41 (m, 2H), 3.75-3.99 
(m, 4H), 4.36 (apparent q, J= 8.3 Hz, lH), 5.90 (d, J= 1.5 Hz, lH), 
5.91 (d, J= 1.5 Hz, lH), 6.47 (dd, J= 1.6, 7.9 Hz, lH), 6.55 (d, J = 
1.6 Hz, lH), 6.66 (d, J=7.9 Hz, lH),6.71 (d, J=9.3 Hz, lH),6.90 (s, 
lH), 6.98 (s, lH), 7.17-7.28 (m, 5H), 7.70 (dd, J=3.1, 5.6 Hz, 2H), 
7.82 (dd, J = 3.1, 5.6 Hz, 2H). LRMS (MALDI-TOF) o-cyano-4-hydrox- 
ycinnamic acid matrix: mass calc’d for C,,Hs,N,O,Br (MH+) 772.2, 
found 772.5. 
FHO. ‘H NMR (400 MHz, CDCI,) 6 2.65 (t, J= 7.2 Hz, 2H), 2.82 (t, J 
=7.6Hz, 2H), 2.91 (m, 2H), 3.07 (dd, J = 2.2, 14.3 Hz, lH), 
3.34-3.49 (m, 2H), 3.63 (dd, J = 8.9, 14.3 Hz, lH), 3.83 (d, J = 
8.4Hz, 1 H), 3.94 (m, 2H), 4.20 (apparent q, J=8.0 Hz, 1 H), 4.38 (d, J 
= 14.8 Hz, lH), 4.46 (d, J= 14.8 Hz, lH), 6.76 (dd, J3.0, 8.9 Hz, 
1 H), 6.92 (d, J = 9.4 Hz, 1 H), 7.00 (d, J = 8.2 Hz, 1 H), 7.02 (d, J = 
3.0 HZ, lH), 7.15 (dd, J= 2.1, 8.2 Hz, lH), 7.18-7.27 (m, 5H), 7.34 
(d, J = 8.9 Hz, 1 H), 7.73 (dd, J = 3.0, 5.4 Hz, 2H), 7.84 (dd, J = 3.0, 
5.4Hz, 2H). FABHRMS: m/e 756.1204 (M++H, C,,H,,N,O,CI, 
requires 756.1202). 
UHD. ‘H NMR (300 MHz, CDCI,) 6 2.29 (s, 3H), 2.38-2.57 (m, 2H), 
2.68 (t, J= 7.2 Hz, 2H), 2.93 (m, 2H), 3.03 (dd, J= 1.6, 14.2 Hz, lH), 
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3.34-3.48 (m, 2H), 3.71 (dd, J = 9.0, 14.2 Hz, lH), 3.81-3.91 (m, 
3H),4.19(apparentq,J=8.1, lH),4.41 (d,J=14.3, lH),4.50(d,f= 
14.3 Hz, 1 t+), 6.91-6.98 (m, 2H), 7.05 (d, I= 8.3 Hz, 2H), 7.17-7.28 
(m, 5H), 7.50 (s, IH), 7.67 (s, IH), 7.71 (dd,J=3.0, 5.5H.2, 2H), 7.83 
(dd, J = 3.0, 5.5 Hz, 2H). LRMS (MALDI-TOF) ol-cyano-4-hydroxycin- 
namic acid matrix: mass calc’d for C,,H,,N,O,CI, (MH+) 736.2, 
found 736.3. 
Cathepsin D assay 
The cathepsin D assay for the compounds that had been fully charac- 
terized was performed in a quartz cuvette with a Perkin-Elmer LS-50B 
spectrometer. The assay was performed in 0.1 M  formic acid buffer 
(pH = 3.7) with 2.5 p,M peptide substrate and 10 nM cathepsin D. Inhi- 
bition constants (Ki) were determined from IC,, values taken from plots 
of Vi/V, versus inhibitor concentration, where V, is the velocity in 
absence of the inhibitor and V, is the velocity with inhibitor. Because the 
substrate concentration is significantly below K,, the IC,, values were 
converted to Ki by the equation Ki =(I&, - E,/2), where E, = enzyme 
concentration [381. 
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